检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Once-daily indacaterol/glycopyrronium reduces the rate and risk of moderate or severe exacerbations compared with twice-daily salmeterol/fluticasone in a subset of gold froup D COPD patients with a history of >= 2 exacerbations or 1 hospitalization: the FLAME study

C Vogelmeier,Jadwiga A. Wedzicha,J Donohue, Sebastian Fucile,Anthony Yadao, Tim Ayers,Chau Thach,Angel FowlerTaylor,Robert Fogel,Francesco Patalano,Donald Banerji

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2018）

引用 1|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要